Anal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Anal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer [Phase 2]
Clinical Trial Update describes a Phase 2 study evaluating a therapy adapted for high-risk and low-risk HIV-associated anal cancer, with the…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas [Phase 1]
Phase 1 study evaluating safety, efficacy, and pharmacokinetics of EVOLVE104 in patients with advanced urothelial cancer and squamous cell c…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients [Phase 3]
This entry describes a Phase 3 clinical trial evaluating carboplatin and paclitaxel with or without nivolumab in metastatic or unresectable …
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors [Phase 2]
A Phase 2 trial investigates the combination of atezolizumab and bevacizumab in several rare solid tumors, with the study currently not recr…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach [Phase 2]
A Phase 2 clinical trial evaluating MR-Adaptive Radiation Therapy with escalated treatment in a risk-optimized approach for anal squamous ce…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: HPV ctDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Advanced-Stage Anal Cancer [Phase 2]
A Phase 2 clinical trial is evaluating HPV DNA–guided chemoradiation with or without the PD-1 inhibitor retifanlimab for advanced anal cance…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Adaptive Radiation in Anal Cancer [NA]
A clinical trial investigating adaptive radiation for anal squamous cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Screening Strategies Among High-risk Populations for Anal Cancer [NA]
This clinical trial update reports a study evaluating screening strategies for high-risk populations to detect anal cancer, including HPV-re…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
A clinical trial focused on identifying the pathogenetic mechanisms underlying squamous cell carcinomas of the head and neck and anus; curre…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. [NA]
Clinical trial investigating screening for anal cancer in women with high-grade vulvar dysplasia or vulvar cancer; currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Proton Versus Photon Therapy in Anal Squamous Cell Carcinoma [NA]
A clinical trial at Umeå University is currently recruiting to compare proton therapy versus photon therapy for anal squamous cell carcinoma…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: A Global Record of Patients With Anal Squamous Cell Carcinoma With and Without HIV Infection
A global registry study by the Latin American Cooperative Oncology Group collecting data on patients with anal squamous cell carcinoma, with…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: High Resolution Anuscopy Study
A status update indicates that the High Resolution Anuscopy study is currently recruiting, investigating its use in anal squamous cell carci…
-
CLINICAL_TRIALS research · 2024-07-17Clinical Trial Update: Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating autologous SCG142 TCR T cells for HPV16/52-positive squamous cell carcinomas across multiple HPV-related sites; c…